Press releases
DexTech strengthens board ahead of myeloma study
7 October, 2021DexTech strengthens board ahead of myeloma study DexTech Medical AB (“DexTech”) intends, as previously communicated, to conduct a clinical proof of concept study regarding the company’s main candidate OsteoDex (ODX) […]
Dextech Medical AB Annual report 200701 – 210630
28 September, 2021Download annual report below. DexTech Medical AB Annual report 200701-210630
Year-end report July 1, 2020 – June 30, 2021
30 August, 2021Summary of the Fourth Quarter (April 1 – June 30, 2021) • Net sales amounted to MSEK 0,0 (0,0) • Operating profit/loss amounted to MSEK -1,5 (-1,9) • Earnings per […]
DexTech is planning a new clinical study on multiple myeloma
24 August, 2021DexTech announces that OsteoDex ́ (ODX) pre-clinical results regarding the effect on multiple myeloma (MM) are so convincing that the company now plans a clinical “proof of concept study” (short […]
DexTech confirms very positive results from myeloma studies
10 May, 2021At the beginning of the year, the company announced positive results from initial in vitro studies regarding OsteoDex (ODX) effect on multiple myeloma (MM). MM is a form of blood […]
Interim report July 1, 2020 – March 31, 2021
20 April, 2021Summary of the Nine-Month period (2019-07-01 – 2020-03-31) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss amounted to MSEK -4,6 (-5,8) Earnings per share * SEK -0.31 (-0.39) Cash […]
Half Year report July 1 – December 31, 2020
2 February, 2021Summary of the First Half Year (2020-07-01 – 2020-12-31) • Net sales amounted to MSEK 0.0 (0.0) • Operating profit/loss amounted to MSEK -3.1 (-3.9) • Earnings per share * […]
DexTech receives positive results regarding multiple myeloma
1 February, 2021DexTech can announce that the company is expanding its preclinical program to also include research into the effect of OsteoDex on multiple myeloma, (MM), in vitro, cell cultures. MM is […]
Interim report July 1 – September 30, 2020
22 October, 2020By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. First Quarter Summary (July – September 2020) • Net sales amounted to MSEK 0.0 (0.0) • Operating […]
Report from the annual general meeting in DexTech Medical AB on 8 October 2020
8 October, 2020Today, October 8, 2020, the Annual General Meeting of DexTech Medical AB was held. Below is a summary of the decisions that were made. All decisions were made with the […]